Normal 0 false false false MicrosoftInternetExplorer4 Immunomedics, Inc.(NASDAQ: IMMU) shares gained 1.9% to $3.19. The company says it’s developed two bispecific, hexavalent antibodies using it’s patented technology for targeted therapies of various epithelial cancers. Share volume was 700 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman"; mso-ansi-language:#0400; mso-fareast-language:#0400; mso-bidi-language:#0400;}